Staphylococcus aureus virulence factors associated with infected skin lesions: Influence on the local immune response

Archives of Dermatology

Volumn 143, Issue 10, 2007, Pages 1259-1263

  Mertz, Patricia M ^a   Cardenas, Tatiana C P ^b   Snyder, Richard V ^b   Kinney, Megan A ^c   Davis, Stephen C ^b   Plano, Lisa R W ^b  

^a Miami Dermatology and Laser Institute   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BACTERIAL TOXIN; EXFOLIATIN; PANTON VALENTINE LEUKOCIDIN; VIRULENCE FACTOR;

ARTICLE; BACTERIAL CHROMOSOME; BACTERIUM CULTURE; CONTROLLED STUDY; GRAM STAINING; IMMUNOMODULATION; LEUKOCYTE COUNT; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SKIN DEFECT; SKIN INFECTION; STAPHYLOCOCCUS AUREUS;

ANTIBODY FORMATION; BACTERIAL TOXINS; ENTEROTOXINS; EXFOLIATINS; EXOTOXINS; HUMANS; LEUKOCIDINS; LEUKOCYTE COUNT; PROTEIN ISOFORMS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; VIRULENCE FACTORS;

EID: 35349026669     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.143.10.1259     Document Type: Article

References (27)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339(8):520-532.
2. Diep BA, Carleton HA, Chang RF, Sensabaugh GF, Perdreau-Remington F. Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis. 2006;193(11):1495-1503.
3. Arbuthnott JP, Coleman DC, de Azavedo JS. Staphylococcal toxins in human disease. Soc Appl Bacteriol Symp Ser. 1990;19:101S-107S.
4. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002;359(9308):753-759.
5. Lina G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29(5):1128-1132.
6. Capoluongo E, Giglio AA, Lavieri MM, et al. Genotypic and phenotypic characterization of Staphylococcus aureus strains isolated in subjects with atopic dermatitis. Higher prevalence of exfoliative B toxin production in lesional strains and correlation between the markers of disease intensity and colonization density. J Dermatol Sci. 2001;26(2):145-155.
7. Lina G, Gillet Y, Vandenesch F, Jones ME, Floret D, Etienne J. Toxin involvement in staphylococcal scalded skin syndrome. Clin Infect Dis. 1997;25(6):1369-1373.
8. Foster TJ. Immune evasion by staphylococci. Nat Rev Microbiol. 2005;3(12):948-958.
9. Jarraud S, Mougel C, Thioulouse J, et al. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun. 2002;70(2):631-641.
10. Jarraud S, Cozon G, Vandenesch F, Bes M, Etienne J, Lina G. Involvement of enterotoxins G and I in staphylococcal toxic shock syndrome and staphylococcal scarlet fever. J Clin Microbiol. 1999;37(8):2446-2449.
11. Sharma NK, Rees CE, Dodd CE. Development of a single-reaction multiplex PCR toxin typing assay for Staphylococcus aureus strains. Appl Environ Microbiol. 2000;66(4):1347-1353.
12. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2002;46(7):2155-2161.
13. de Haas CJ, Veldkamp KE, Peschel A, et al. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med. 2004;199(5):687-695.
14. Larsen HD, Aarestrup FM, Jensen NE. Geographical variation in the presence of genes encoding superantigenic exotoxins and beta-hemolysin among Staphylococcus aureus isolated from bovine mastitis in Europe and USA. Vet Microbiol. 2002;85(1):61-67.
15. Dancer SJ, Noble WC. Nasal, axillary, and perineal carriage of Staphylococcus aureus among women: identification of strains producing epidermolytic toxin. J Clin Pathol. 1991;44(8):681-684.
16. Becker K, Friedrich AW, Lubritz G, Weilert M, Peters G, Von Eiff C. Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens. J Clin Microbiol. 2003;41(4):1434-1439.
17. Prevost G, Bouakham T, Piemont Y, Monteil H. Characterisation of a synergohymenotropic toxin produced by Staphylococcus intermedius. FEBS Lett. 1995;376(3):135-140.
18. Peacock SJ, Moore CE, Justice A, et al. Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect Immun. 2002;70(9):4987-4996.
19. Rooijakkers SH, Ruyken M, Roos A, et al. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol. 2005;6(9):920-927.
20. Wagner C, Iking-Konert C, Hug F, et al. Cellular inflammatory response to persistent localized Staphylococcus aureus infection: phenotypical and functional characterization of polymorphonuclear neutrophils (PMN). Clin Exp Immunol. 2006;143(1):70-77.
21. Amagai M, Matsuyoshi N, Wang ZH, Andl C, Stanley JR. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat Med. 2000;6(11):1275-1277.
22. Dusek RL, Godsel LM, Green KJ. Discriminating roles of desmosomal cadherins: beyond desmosomal adhesion. J Dermatol Sci. 2007;45(1):7-21.
23. Chernyavsky AI, Arredondo J, Kitajima Y, Sato-Nagai M, Grando SA. Desmoglein versus nondesmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens. J Biol Chem. 2007;282(18):13804-13812.
24. Berkowitz P, Hu P, Liu Z, et al. Desmosome signaling: inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization. J Biol Chem. 2005;280(25):23778-23784.
25. Monday SR, Vath GM, Ferens WA, et al. Unique superantigen activity of staphylococcal exfoliative toxins. J Immunol. 1999;162(8):4550-4559.
26. Labandeira-Rey M, Couzon F, Boisset S, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science. 2007;315(5815):1130-1133.
27. Voyich JM, Otto M, Mathema B, et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis. 2006;194(12):1761- 1770.